Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study
Open Access
- 31 May 2007
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 132 (5), 1746-1756
- https://doi.org/10.1053/j.gastro.2007.03.041
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis: (Paris, France, January 12–14, 2006)Journal of Hepatology, 2006
- Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis CLiver Transplantation, 2006
- Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantationHepatology, 2004
- Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized studyGastroenterology, 2003
- Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis CLiver Transplantation, 2002
- A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis CHepatology, 2002
- The association between hepatitis C infection and survival after orthotopic liver transplantationGastroenterology, 2002
- Hepatitis C virus kinetics during and immediately after liver transplantationHepatology, 2002
- IMPACT OF THE RECURRENCE OF HEPATITIS C VIRUS INFECTION AFTER LIVER TRANSPLANTATION ON THE LONG-TERM VIABILITY OF THE GRAFT1Transplantation, 2002
- High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodesHepatology, 1999